Shanghai HeartCare Medical Technology (HKSE:06609) Cash Flow for Dividends: HK$0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06609 Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
78 GF Score
Price HK$48.24
GF Value HK$54.80
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Shanghai HeartCare Medical Technology Cash Flow for Dividends?

Shanghai HeartCare Medical Technology HKSE:06609 -4.29% 78 Cash Flow for Dividends is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:06609 with a GF Score™ of 78/100 and a GF Value™ of HK$54.80 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Shanghai HeartCare Medical Technology's cash flow for dividends for the six months ended in Dec. 2025 was HK$0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Shanghai HeartCare Medical Technology Cash Flow for Dividends Related Terms

Shanghai HeartCare Medical Technology Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Shanghai HeartCare Medical Technology's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai HeartCare Medical Technology Cash Flow for Dividends Chart

Shanghai HeartCare Medical Technology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Shanghai HeartCare Medical Technology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:06609
78GF Score
Shanghai HeartCare Medical Technology Corp Ltd HKSE:06609
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai HeartCare Medical Technology Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of HK$0.0 Mil mean?
Shanghai HeartCare Medical Technology (HKSE:06609) has a Cash Flow for Dividends of HK$0.0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shanghai HeartCare Medical Technology and its competitors.
Is Shanghai HeartCare Medical Technology's Cash Flow for Dividends too high?
Shanghai HeartCare Medical Technology's current Cash Flow for Dividends is HK$0.0 Mil. Overall, Shanghai HeartCare Medical Technology has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai HeartCare Medical Technology's Cash Flow for Dividends compare to ABT and SYK?
Shanghai HeartCare Medical Technology's Cash Flow for Dividends of HK$0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Medical Devices & Instruments company?
A good Cash Flow for Dividends depends on the Medical Devices & Instruments industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Shanghai HeartCare Medical Technology and its competitors. Shanghai HeartCare Medical Technology's current Cash Flow for Dividends is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai HeartCare Medical Technology stock overvalued right now?
Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology (HKSE:06609) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$54.80, compared to a current price of HK$48.24 — trading 12% below its estimated fair value. The current Cash Flow for Dividends is HK$0.0 Mil. Shanghai HeartCare Medical Technology's overall GF Score™ is 78/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Shanghai HeartCare Medical Technology (HKSE:06609), the current Cash Flow for Dividends is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai HeartCare Medical Technology (HKSE:06609) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai HeartCare Medical Technology stock appears to be undervalued. The current stock price of HK$48.24 is trading 12% below its estimated GF Value™ of HK$54.80. GuruFocus considers Shanghai HeartCare Medical Technology to be Modestly Undervalued.

Key valuation signals for HKSE:06609:

  • Cash Flow for Dividends: HK$0.0 Mil
  • GF Value™: HK$54.80 vs. price of HK$48.24 (12% below fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the HKSE:06609 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai HeartCare Medical Technology Business Description

Address No. 356, Zhengbo Road, Floor 1 and 3, Building 38, Pilot Free Trade Zone, Lingang New District, Shanghai, CHN
Shanghai HeartCare Medical Technology Corp Ltd is an neuro-interventional medical device company. The company is committed to creating high-quality products for the prevention and treatment of stroke. The company focuses on Research and development, manufacturing and commercialization to fulfill the unmet needs of clinicians and patients to redefine the standard of care, reduce mortality rate, and improve prognosis by continuously launching new medical devices. Geographically, the Group's majority revenue is derived from Chinese Mainland.
78GF Score

Get the complete analysis for HKSE:06609

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$48.24
Price
HK$54.80
GF Value